Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Emma Zattarin

8PUBLICATIONS
38CO-AUTHORS
Cancer diagnosisCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Jul 16, 2025
Breast cancer and large-cell neuroendocrine carcinoma harboring the same <i>PIK3CA</i> mutation: A case report.

Emma Zattarin, Teresa Beninato, Giorgia Di Liberti

|Jul 01, 2025
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade.

Emma Zattarin, Luca Moscetti, Elisa D'Agostino

|Dec 22, 2023
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.

Emma Zattarin, Luigi Mariani, Alice Menichetti

|Oct 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research.

Fabio Conforti, Laura Pala, Tommaso De Pas

|Apr 17, 2023
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.

Leonardo Provenzano, Riccardo Lobefaro, Francesca Ligorio

|Jun 20, 2022
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.

Emma Zattarin, Sara Manglaviti, Giulia Apollonio

Pageof 2

Frequent Collaborators

2 joint publications

Achille Bottiglieri

2 joint publications

Caterina Sposetti

2 joint publications

Rita Leporati

1 joint publications

Federico Nichetti

1 joint publications

Stefano Cavalieri

1 joint publications

Daria Maria Filippini

1 joint publications

Cristiana Bergamini

1 joint publications

Roberto Ferrara

1 joint publications

Giuseppe Lo Russo

1 joint publications

Arsela Prelaj

Frequent Collaborators

2 joint publications

Achille Bottiglieri

2 joint publications

Caterina Sposetti

2 joint publications

Rita Leporati

1 joint publications

Federico Nichetti

Top Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on : Feb 04, 2021

3.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

381
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

2.7K
See more related videos

Top Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on : Feb 04, 2021

3.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

381
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

2.7K
See more related videos